Elyxium Wealth Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$3.69B |
| 2 |
Ciena
CIEN
|
+$2.28B |
| 3 |
Avantis International Equity ETF
AVDE
|
+$7.39M |
| 4 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$2.8M |
| 5 |
IQ MacKay Municipal Intermediate ETF
MMIT
|
+$2.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.1M |
| 2 |
Apple
AAPL
|
+$1.72M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$1.36M |
| 4 |
Procter & Gamble
PG
|
+$777K |
| 5 |
Victory Portfolios II VictoryShares Short-Term Bond ETF
USTB
|
+$775K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.11% |
| 2 | Financials | 9.42% |
| 3 | Consumer Discretionary | 6.23% |
| 4 | Industrials | 5.4% |
| 5 | Communication Services | 5.25% |
Similar funds
Elyxium Wealth's Q4 2025 Portfolio in Review
As of Q4 2025, Elyxium Wealth held 1,359 positions worth $361M, up 26% from $287M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Elyxium Wealth deployed $6.02B of net new capital in Q4 2025, opening 1,192 new positions and adding to 77 existing holdings. Its largest new stake was Idexx Laboratories: 5,419,507 shares worth $5.44M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $2.1M trimmed.
- Elyxium Wealth's largest Q4 2025 buy was Idexx Laboratories: 5,419,507 shares worth $5.44M.
- Elyxium Wealth added most to IQ MacKay Municipal Intermediate ETF in Q4 2025, an estimated $2.24M increase.
- Elyxium Wealth's biggest Q4 2025 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.1M.
- Elyxium Wealth's ten largest holdings make up 34% of its $361M portfolio in Q4 2025.
- Elyxium Wealth opened 1,192 new positions and closed 0 in Q4 2025.
- Elyxium Wealth's portfolio value rose 26% quarter-over-quarter to $361M.
Based on Elyxium Wealth's 13F filing for Q4 2025, filed 5 Feb 2026.